Tag: Onvansertib

Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib

Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib

| December 13, 2018 | 0 Comments

We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies are being developed in an effort to bring improved treatment options to patients, especially for some of the toughest-to-treat cancers. That’s where Trovagene (Nasdaq: TROV) comes in with their drug candidate, Onvansertib. Trovagene caught my attention […]

Continue Reading